About Pharmasset (NASDAQ:VRUS)
Pharmasset, Inc. is a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing novel drugs to treat viral infections. The Company focuses on the development of nucleoside/tide analogs as oral therapeutics for the treatment of chronic hepatitis C virus (HCV) infection. Nucleoside/tide analogs are a class of compounds, which act as alternative substrates for the viral polymerase, thus inhibiting viral replication. The Company has three clinical-stage product candidates. It also has a series of preclinical candidates in preparation for clinical development. The three clinical product candidates include RG7128, PSI-7977 and PSI-938. In January 2012, Gilead Sciences, Inc. acquired Pharmasset, Inc.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Pharmasset (NASDAQ:VRUS) Frequently Asked Questions
What is Pharmasset's stock symbol?
Pharmasset trades on the NASDAQ under the ticker symbol "VRUS."
Who are some of Pharmasset's key competitors?
Some companies that are related to Pharmasset include Johnson & Johnson (JNJ), Novartis (NVS), UnitedHealth Group (UNH), Pfizer (PFE), Roche (ROG), AbbVie (ABBV), Merck & Co., Inc. (MRK), Amgen (AMGN), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), Sanofi (SNY), GlaxoSmithKline (GSK), Eli Lilly and (LLY), Thermo Fisher Scientific (TMO), Sanofi (SAN) and Bayer (BAYN).
How do I buy Pharmasset stock?
Shares of Pharmasset can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Pharmasset?
Pharmasset's mailing address is 303A College Rd E, PRINCETON, NJ 08540-6608, United States. The healthcare company can be reached via phone at +1-609-6134100.
MarketBeat Community Rating for Pharmasset (VRUS)MarketBeat's community ratings are surveys of what our community members think about Pharmasset and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Pharmasset (NASDAQ:VRUS) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Pharmasset (NASDAQ:VRUS) Earnings History and Estimates Chart
Pharmasset (NASDAQ VRUS) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Pharmasset (NASDAQ:VRUS) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Pharmasset (NASDAQ:VRUS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Pharmasset (NASDAQ VRUS)
No insider trades for this company have been tracked by MarketBeat.com
Pharmasset (NASDAQ VRUS) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Pharmasset (NASDAQ:VRUS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Pharmasset (NASDAQ:VRUS) Income Statement, Balance Sheet and Cash Flow Statement
Pharmasset (NASDAQ VRUS) Stock Chart for Tuesday, February, 20, 2018